Skip to content

Angina Pectoris: clinical trials and information

"Angina Pectoris" is the term study registrants used on ClinicalTrials.gov. Registry labels are not always standard medical terms, and close variants of the same label appear as separate entries. In this snapshot the term appears on 24 chronic pain registry records worldwide.
3
Trials with Canadian sites
0
Recruiting in Canada
24
Registry records worldwide

Angina Pectoris clinical trials in Canada

3 trials, recruiting first
PhaseProvinces
Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina
NCT01659580
CompletedPhase 3British Columbia, Ontario, QuebecTasly Pharmaceuticals, Inc.2012-08
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
NCT01442038
CompletedPhase 3Alberta, New Brunswick, Ontario, QuebecGilead Sciences2011-10
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
NCT01425359
CompletedPhase 4Ontario, QuebecGilead Sciences2011-09

Angina Pectoris clinical trials worldwide (outside Canada)

21 trials, 2 recruiting or not yet recruiting. Recruiting first.

PhaseCountries
COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLEX and Calcified Coronary Artery Disease
NCT06075602
RecruitingSwitzerlandLuzerner Kantonsspital2021-11-01
SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With SIROlimus Or Paclitaxel Eluting Balloon Catheters
NCT04988685
RecruitingSwitzerlandLuzerner Kantonsspital2021-06-01
Benidipine in Hypertensive and/or Chronic Coronary Syndrome Patients
NCT06808321
Enrolling by invitationTurkey (Türkiye)The Society of Prevention and Awareness of Cardiovascular Diseases2025-03-01
Personalized Evaluation of Susptected Myocardial Ischemia
NCT06708000
Enrolling by invitationPhase 3DenmarkGødstrup Hospital2024-11-20
Volatilome and Single-Lead Electrocardiogram Optimize Ischemic Heart Disease Diagnosis Using Machine Learning Models
NCT06181799
CompletedRussiaI.M. Sechenov First Moscow State Medical University2023-11-01
Invest-CTO PCI Trial
NCT04774913
Active, not recruitingNot applicableNorway, United Kingdom, United StatesHaukeland University Hospital2021-12-08
Observational Registry on Clinical Outcome After Diagnosis of Chronic Total Occlusions
NCT04145167
Unknown statusBelgiumZiekenhuis Netwerk Antwerpen (ZNA)2019-10-10
The NOrdic-Baltic Randomized Registry Study for Evaluation of PCI in Chronic Total Coronary Occlusion
NCT03392415
Active, not recruitingNot applicableDenmarkLeif Thuesen2018-06-01
Appropriateness of Angioplasty in Patients With Chronic Coronary Syndromes
NCT06545448
Unknown statusBrazilUniversity of Sao Paulo General Hospital2017-12-01
Chronic Total Coronary Occlusion Treatment Results 6 Years After Bioresorbable Scaffold Implantation
NCT06164977
CompletedNot applicableLatviaPauls Stradins Clinical University Hospital2017-02-01
REDUCER-I: An Observational Study of the Neovasc Reducer™ System
NCT02710435
Active, not recruitingAustria, Belgium, France, Germany and 5 moreShockwave Medical, Inc.2016-03
Intracoronary Thrombus Detection by Magnetic Resonance Imaging
NCT02776657
CompletedNot applicableUniversity of Edinburgh2016-01-14
Change in Exercise Capacity as Measured by Peak Oxygen Uptake After CTO PCI
NCT02499666
TerminatedUnited StatesHenry Ford Health System2015-06-29
To Assess the Anti-anginal Safety and Efficacy of Ivabradine in Subjects With Stable,Symptomatic Chronic Angina
NCT02623569
Unknown statusPhase 2ChinaXintong Pharmacy Company2014-10
A Study on the Effects of Ranolazine on Exercise Duration in Subjects With Chronic Stable Angina and Coronary Artery Disease (CAD) With Type 2 Diabetes Mellitus (T2DM)
NCT01334203
WithdrawnPhase 4Gilead Sciences2011-05
Phase II Multi-Center Study of T89 to Treat Chronic Stable Angina
NCT00797953
CompletedPhase 2United StatesTasly Pharmaceuticals, Inc.2007-02
Rosiglitazone Versus Placebo in Chronic Stable Angina
NCT00225355
TerminatedPhase 4United KingdomUniversity of Glasgow2006-02
Cell Therapy in Severe Chronic Ischemic Heart Disease
NCT01727063
CompletedPhase 3BrazilMinistry of Health, Brazil2006-01
Testosterone Therapy on Angina Threshold and Atheroma in Patients With Chronic Stable Angina
NCT00131183
CompletedPhase 4United KingdomSheffield Teaching Hospitals NHS Foundation Trust2005-09
Efficacy and Safety of Lacidipine in Chronic Stable Angina
NCT02232607
CompletedPhase 2Boehringer Ingelheim1998-04
Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With Angina
NCT00225342
WithdrawnPhase 4United KingdomUniversity of Glasgow

About Angina Pectoris

What is Angina Pectoris?

"Angina Pectoris" is the term study registrants used on ClinicalTrials.gov. Registry labels are not always standard medical terms, and close variants of the same label appear as separate entries. In this snapshot the term appears on 24 chronic pain registry records worldwide.

How is Angina Pectoris usually assessed?

Assessment of chronic pain generally involves a clinician taking a detailed history, a physical examination and, where relevant, tests to look for underlying causes. Pain rating scales and questionnaires about function, sleep and mood are often used. The approach depends on the person and the condition.

What kinds of treatments are studied for Angina Pectoris?

Registered studies cover medicines, medical devices (such as nerve stimulators), procedures (such as nerve blocks or injections), physical and movement therapies, psychological approaches (such as cognitive behavioural therapy), education programs and digital tools. Being studied in a trial does not mean a treatment works or is approved. The interventions listed on this page come directly from the registry records.

How can I find Angina Pectoris clinical trials in Canada?

This page lists 3 registry records for this term with at least one site in Canada, recruiting studies first. Each trial page links to the official ClinicalTrials.gov record, which lists the study contacts. Recruiting status changes often, so check the registry, and talk to your doctor before joining a study.

Related conditions

Related interventions

Related US FDA drug labels

Labels whose indications text mentions this term. US labels, not Health Canada Product Monographs.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.